reference/32151720

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32151720

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Controlled Clinical Trial\|Journal Article
endingPage	1126
issn	1538-7836
issueIdentifier	7
pageRange	1118-1126
publicationName	Journal of thrombosis and haemostasis : JTH
startingPage	1118
bibliographicCitation	Morel O, Hugel B, Jesel L, Mallat Z, Lanza F, Douchet M, Zupan M, Chauvin M, Cazenave J, Tedgui A, Freyssinet J, Toti F. Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb‐IIIa antagonists. Journal of Thrombosis and Haemostasis. 2004 Jul;2(7):1118–26. doi: 10.1111/j.1538-7836.2004.00805.x.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f281dfee10ee9ef8e0fb792a4218ef52 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d33a92445c4d9051ce27d6f3e0feb344 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7470c73f8eb0c660b433cac2d3acf1ba http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2d5804fe82be64c0fb10586339f8cff9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ce2972bf322e9575b4dda7c35b3146e4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_51ac69d8479311805fd3243e7e0bdbf2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d580153a9c7fdd1240b9f3e6f2745d23 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_14952fc87aea6e746d9831fd3f4428b4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1980427a9c63cd17154d3e896f78c930 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4b4a22e20c3bceacaa09001167072376 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d10ca116a104b27e1db06eafa44beb3e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_49d523e0cd4338b47725c9b15f39f7c2
date	200407
identifier	https://doi.org/10.1111/j.1538-7836.2004.00805.x https://pubmed.ncbi.nlm.nih.gov/15219195
isPartOf	https://portal.issn.org/resource/ISSN/1538-7836 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30450
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb‐IIIa antagonists
discusses	http://id.nlm.nih.gov/mesh/M0017012 http://id.nlm.nih.gov/mesh/M0227707 http://id.nlm.nih.gov/mesh/M0023752 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0028417 http://id.nlm.nih.gov/mesh/M0028424 http://id.nlm.nih.gov/mesh/M0011126 http://id.nlm.nih.gov/mesh/M0001864 http://id.nlm.nih.gov/mesh/M0000495
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D015906Q000009 http://id.nlm.nih.gov/mesh/D009203Q000097 http://id.nlm.nih.gov/mesh/D019851Q000188 http://id.nlm.nih.gov/mesh/D019038Q000032 http://id.nlm.nih.gov/mesh/D010975Q000494 http://id.nlm.nih.gov/mesh/D019039Q000037
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000911Q000494 http://id.nlm.nih.gov/mesh/D001241Q000627 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D019851Q000209 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D009203Q000628 http://id.nlm.nih.gov/mesh/D015415Q000097 http://id.nlm.nih.gov/mesh/D019038Q000187 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D007140Q000627 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000319Q000627 http://id.nlm.nih.gov/mesh/D007140Q000494 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D019851Q000175 http://id.nlm.nih.gov/mesh/D010316 http://id.nlm.nih.gov/mesh/D011237 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D010975Q000627 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D012995 http://id.nlm.nih.gov/mesh/D000077284 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D000911Q000627
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6897 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10417847 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9b21d1a174c364b6f99c6662d34d6034 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3667f6a0c97490758d7dc9659d01ea34 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.21.6 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_744117db1e81ab1e4aebb6f186b13f7d http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6592 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID133612130 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9e3669d19b675bd57058fd4664205d2a http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9547096

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695

Total number of triples: 81.